C5 inhibitor Eculizumab

Monoclonal antibody therapy

Monoclonal
Monoclonal antibody therapy is the use of monoclonal antibodies (or mAb) to specifically bind to target cells. This may then stimulate the patient's immune system to attack those cells. It is possible to create a mAb specific to almost any extracellular/ cell surface target, and thus there is a large amount of research and development currently being undergone to create monoclonals for numerous serious diseases. There are a number of ways that mAbs can be used for therapy. For example: mAb therapy can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors...

C5 inhibitor Eculizumab - List of case studies

Treatments

Arm A (IFN with high intensified doses) Aromatase inhibitor Arthroeresis technique Arthrolysis Arthroscopic ... C section C-met inhibitors C4-5 fusion C5 inhibitor Eculizumab C5-6 and C6-7 discectomy and fusion CBT ...

End Stage Renal Disease

meeting last week in Boston a novel approach using C5 inhibitor eculizumab in the prevention of acute humoral rejection in highly ...

JustAnswer.com